Most Siewert type II esophagogastric junction adenocarcinomas in Chinese patients lack a Barrett esophagus background

Kusano, 2008, Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan, J Gastroenterol Hepatol, 23, 1662, 10.1111/j.1440-1746.2008.05572.x Committee of Korean Gastric Cancer Association, 2016, Korean gastric Cancer association Nationwide survey on gastric Cancer in 2014, J Gastric Cancer, 16, 131, 10.5230/jgc.2016.16.3.131 Liu, 2016, Changes of esophagogastric junctional adenocarcinoma and gastroesophageal reflux disease among surgical patients during 1988-2012: a single-institution, high-volume experience in China, Ann Surg, 263, 88, 10.1097/SLA.0000000000001148 von Rahden, 2005, Carcinoma of the cardia: classification as esophageal or gastric cancer?, Int J Color Dis, 20, 89, 10.1007/s00384-004-0646-9 Gertler, 2011, How to classify adenocarcinomas of the esophagogastric junction: as esophageal or gastric cancer?, Am J Surg Pathol, 35, 1512, 10.1097/PAS.0b013e3182294764 Kumamoto, 2020, True esophagogastric junction adenocarcinoma: background of its definition and current surgical trends, Surg Today, 50, 809, 10.1007/s00595-019-01843-4 Siewert, 1996, Carcinoma of the gastroesophageal junction—classification, pathology and extent of resection, Dis Esophagus, 9, 173 Donohoe, 2017, Cancer of the esophagus and esophagogastric junction: an 8th edition staging primer, J Thorac Dis, 9, E282, 10.21037/jtd.2017.03.39 Hansen, 2007, Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status, Gut, 56, 918, 10.1136/gut.2006.114504 Derakhshan, 2008, Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer, Gut, 57, 298, 10.1136/gut.2007.137364 Yamada, 2014, Different histological status of gastritis in superficial adenocarcinoma of the esophagogastric junction, Jpn J Clin Oncol, 44, 65, 10.1093/jjco/hyt167 Osumi, 2017, Clinicopathological features of Siewert type II adenocarcinoma: comparison of gastric cardia adenocarcinoma and Barrett’s esophageal adenocarcinoma following endoscopic submucosal dissection, Gastric Cancer, 20, 663, 10.1007/s10120-016-0653-x Urabe, 2018, Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: a comparative analysis according to Siewert classification in a Japanese cohort, Cancer Med, 7, 5145, 10.1002/cam4.1763 Uedo, 2017, Endoscopic gastric mucosal atrophy distinguishes the characteristics of superficial esophagogastric junction adenocarcinoma, Dig Endosc, 29, 26, 10.1111/den.12849 Takubo, 2009, Digestion, 80, 248, 10.1159/000235923 Shaheen, 2016, Gerson LB; American College of Gastroenterology. ACG clinical guideline: diagnosis and Management of Barrett’s esophagus, Am J Gastroenterol, 111, 30, 10.1038/ajg.2015.322 Weusten, 2017, Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) position statement, Endoscopy, 49, 191, 10.1055/s-0042-122140 Sharma, 2006, The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C & M criteria, Gastroenterology, 131, 1392, 10.1053/j.gastro.2006.08.032 Kimura, 1969, An endoscopic recognition of the atrophic border and its significance in chronic gastritis, Endoscopy, 1, 87, 10.1055/s-0028-1098086 American Gastroenterological Association, 2011, American Gastroenterological Association medical position statement on the management of Barrett’s esophagus, Gastroenterology., 140, 1084, 10.1053/j.gastro.2011.01.030 Takubo, 2009, Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinoma, Hum Pathol, 40, 65, 10.1016/j.humpath.2008.06.008 Dixon, 1996, Classification and grading of gastritis. The updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994, Am J Surg Pathol, 20, 1161, 10.1097/00000478-199610000-00001 Zhao, 2020, The effect of helicobacter pylori eradication in patients with gastroesophageal reflux disease: a meta-analysis of randomized controlled studies, Dig Dis, 38, 261, 10.1159/000504086 Zamani, 2021, Systematic review with meta-analysis: association of Helicobacter pylori infection with gastro-oesophageal reflux and its complications, Aliment Pharmacol Ther, 54, 988, 10.1111/apt.16585 Erőss, 2018, Helicobacter pylori infection reduces the risk of Barrett’s esophagus: a meta-analysis and systematic review, Helicobacter., 23, 10.1111/hel.12504 Hatta, 2017, Different time trend and management of esophagogastric junction adenocarcinoma in three Asian countries, Dig Endosc, 29, 18, 10.1111/den.12808 Ishihara, 2014, Endoscopic submucosal dissection for superficial Barrett’s esophageal cancer in the Japanese state and perspective, Ann Transl Med, 2, 24 Wu, 2008, Gastroesophageal reflux disease: an Asian perspective, J Gastroenterol Hepatol, 23, 1785, 10.1111/j.1440-1746.2008.05684.x Hongo, 2009, Epidemiology of esophageal cancer: orient to occident. Effects of chronology, geography and ethnicity, J Gastroenterol Hepatol, 24, 729, 10.1111/j.1440-1746.2009.05824.x Nagami, 2018, Endoscopic submucosal dissection for adenocarcinomas of the esophagogastric junction, Digestion, 97, 38, 10.1159/000484111 Ubukata, 2011, Why is the coexistence of gastric cancer and duodenal ulcer rare? Examination of factors related to both gastric cancer and duodenal ulcer, Gastric Cancer, 14, 4, 10.1007/s10120-011-0005-9 Usui, 2021, Impact of PSCA polymorphisms on the risk of duodenal ulcer, J Epidemiol, 31, 12, 10.2188/jea.JE20190184